Trial Profile
A Single-dose, Open-Label, Multi-center Study to Assess the Safety and Preliminary Efficacy of PRF 110 (Formerly LNP) in Open Herniorrhaphy Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2020
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Perioperative pain
- Focus Adverse reactions
- Sponsors PainReform
- 12 Nov 2020 Status changed from recruiting to completed.
- 23 Nov 2015 Planned End Date changed from 1 Mar 2013 to 1 Aug 2016 as reported by ClinicalTrials.gov record.
- 17 Sep 2012 New trial record